Determination of liposome/water partition coefficients of salmeterol and budesonide and study on their influencing factors

Yaoxue Xuebao

Volumn 41, Issue 4, 2006, Pages 318-322

  Wang, Zhi Xuan ^a   Deng, Ying Jie ^a   Zhang, Xiao Peng ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Budesonide; Dialysis; Liposome water partition coefficient; Salmeterol

Indexed keywords

BUDESONIDE; CHOLESTEROL; DRUG CARRIER; DRUG DERIVATIVE; ION; LIPOSOME; PHOSPHOLIPID; SALBUTAMOL; SALMETEROL; WATER;

ARTICLE; ARTIFICIAL MEMBRANE; CHEMISTRY; CLASSIFICATION; PH;

ALBUTEROL; BUDESONIDE; CHOLESTEROL; DRUG CARRIERS; HYDROGEN-ION CONCENTRATION; IONS; LIPOSOMES; MEMBRANES, ARTIFICIAL; PHOSPHOLIPIDS; WATER;

EID: 33744921902     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aloia RC, Curtain CC, Gordon LM. Drug and Anesthetic Effects on Membrane Structure and Function [M]. New York: Wiley-Liss, 1991:15-33.
2. Wei C, Xu H, Ma Y, et al. Effect of pH on the permeability of timolol maleate across isolated rabbit cornea [J]. Acta Pharm Sin, 2001, 36; 707-710.
3. Jiang XG, Lu X, Cui JB, et al. Studies on octanol-water partition coefficient and nasal drug absorption [J]. Acta Pharm Sin, 1997, 32:458-460.
4. Choi YW, Rogers JA. The liposome as a model membrane in correlations of partitioning with alpha-adrenoceptor agonist activities [J]. Pharm Res, 1990, 7: 508-512.
5. Barton P, Davis AM, McCarthy DJ, et al. Drug-phospholipid interactions. 2. Predicting the sites of drug distribution using n-octanol/water and membrane/water distribution coefficients [J]. J Pharm Sci, 1997, 86: 1034-1039.
6. Plember van Balen G, Caron G, Ermondi G, et al. Lipophilicity behaviour of the zwitterionic antihistamine cetirizine in phosphatidylcholine liposomes/water systems [J]. Pharm Res, 2001, 18:694-701.
7. Welti R, Mullikin LJ, Yoshimura T, et al. Partition of amphiphilic molecules into phospholipid vesicles and human erythrocyte ghosts: measurements by ultraviolet difference spectroscopy [J]. Biochemistry, 1984, 23: 6086-6091.
8. Mason RP, Gonye GE, Chester DW, et al. Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist, in model and biological membranes [J]. Biophys J, 1989, 55:769-778.
9. Palmeira CM, Oliveira CR. Partitioning and membrane disordering effects of dopamine antagonists: influence of lipid peroxidation, temperature, and drug concentration [J]. Arch Biochem Biophys, 1992, 295:161-171.
10. Rogers JA, Choi YW. The liposome partitioning system for correlating biological activities of imidazolidine derivatives [J]. Pharm Res, 1993, 10:913-917.
11. Nayak VG, Belapure SG, Gaitonde CD, et al. Determination of salmeterol in metered-dose and dry-powder inhalers by reversed-phase high performance liquid chromatography [J]. J Pharm Biomed Anal, 1996, 14:511-513.
12. Liu JA, Wang MX, Wang YM, et al. Determination of budesonide and R-isomer in budesonide aerosol by HPLC [J]. Chin J Pharm, 2003, 34: 461-462.
13. Pauletti GM, Wunderli-Allenspach H. Partition coefficients in vitro: artificial membranes as a standardised distribution model [J]. Eur J Pharm Sci, 1994, 1:273-282.
14. Huang C, Mason JT. Geometric packing constraints in egg phosphatidylcholine vesicles [J]. Proc Natl Acad Sci, 1978, 75:308-310.
15. Lu B. New Techniques and New Dosage Forms of Drugs [M]. Beijing: People's Medical Publishing House, 1998:114.
16. Lis LJ, McAlister M, Fuller N, et al. Interactions between neutral phospholipid bilayer membranes [J]. Biophys J, 1982, 37:657-665.